Allianz Asset Management
ITCI

Allianz Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Allianz Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,100
Closed -$677K – 2392
2024
Q4 		$677K Buy
8,100
+3,100
+62% +$255K ﹤0.01% 1765
2024
Q3 		$366K Buy
+5,000
New +$376K ﹤0.01% 1939
2022
Q3 		– Sell
-12,450
Closed -$711K – 2162
2022
Q2 		$711K Hold
12,450
– – ﹤0.01% 1792
2022
Q1 		$762K Hold
12,450
– – ﹤0.01% 1982
2021
Q4 		$652K Hold
12,450
– – ﹤0.01% 2097
2021
Q3 		$464K Sell
12,450
-5,800
-32% -$202K ﹤0.01% 2261
2021
Q2 		$745K Sell
18,250
-12,635
-41% -$467K ﹤0.01% 1867
2021
Q1 		$1.05M Hold
30,885
– – ﹤0.01% 1623
2020
Q4 		$982K Hold
30,885
– – ﹤0.01% 1484
2020
Q3 		$793K Buy
30,885
+13,226
+75% +$302K ﹤0.01% 1495
2020
Q2 		$454K Sell
17,659
-18,172
-51% -$368K ﹤0.01% 2085
2020
Q1 		$551K Buy
35,831
+7,309
+26% +$159K ﹤0.01% 2020
2019
Q4 		$979K Sell
28,522
-9,042
-24% -$109K ﹤0.01% 2206
2019
Q3 		$281K Buy
37,564
+17,544
+88% +$168K ﹤0.01% 2542
2019
Q2 		$260K Buy
+20,020
New +$257K ﹤0.01% 2538
2016
Q2 		– Sell
-39,452
Closed -$1.1M – 2628
2016
Q1 		$1.1M Sell
39,452
-123,884
-76% -$4.13M ﹤0.01% 2042
2015
Q4 		$8.79M Sell
163,336
-28,902
-15% -$1.46M 0.01% 1115
2015
Q3 		$7.7M Buy
+192,238
New +$6.27M 0.01% 1093

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Allianz Asset Management's ITCI Position: Q1 2025 in Review

Allianz Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 8,100 shares — an estimated $677K sold.

Allianz Asset Management first reported a position in ITCI in Q3 2015 and held it in 18 quarters. The position peaked at $8.79M in Q4 2015. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Allianz Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Allianz Asset Management sold 8,100 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $677K.
  • Allianz Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 18 quarters.
  • Allianz Asset Management's Intra-Cellular Therapies Inc. position peaked at $8.79M in Q4 2015.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Allianz Asset Management's 13F filing for Q1 2025, filed 5 May 2025.